Eagle Pharmaceuticals, Inc.: SCHEDULE 13G/A filed Feb 19, 2025

Form type
SCHEDULE 13G/A
Filing date
Feb 19, 2025
Accession number
0001104659-25-015190
Filer
Eagle Pharmaceuticals, Inc. (CIK 827871)